KORU Medical wins EU notified body appeal, CE certification continues uninterrupted

KORU Medical Systems, Inc.

BSI had recommended against continued certification after March 2024 audit nonconformance.
Appeal upheld April 8, 2024; no suspension or interruption of EU product sales.
Products remain certified, marketed, and sold in EU; proceeds through routine BSI assessment.
CEO Linda Tharby cites swift team response and positive BSI interaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.